| Trade Names: | |
| Synonyms: | |
| Status: | Approved (2016) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| ATC: | R03DX08 |
| UNII: | 35A26E427H |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Interleukin-5 inhibitor | FDA |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Asthma | 4 | D001249 | ClinicalTrials |
| Sinusitis | 3 | D012852 | ClinicalTrials |
| Substance-Related Disorders | 3 | D019966 | ClinicalTrials |
| Eosinophilic Esophagitis | 3 | D057765 | ClinicalTrials |
| Bronchitis | 2 | D001991 | ClinicalTrials |
| Hypereosinophilic Syndrome | 2 | D017681 | ClinicalTrials |
| Loiasis | 2 | D008118 | ClinicalTrials |
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2107884 |
| FDA SRS | 35A26E427H |
| Guide to Pharmacology | 8091 |
CONTENTS